Prevalence of protease and reverse transcriptase drug resistance mutations over time in drug-naive human immunodeficiency virus type 1-positive individuals in Rio de Janeiro, Brazil

被引:36
作者
Dumans, AT
Soares, MA
Pieniazek, D
Kalish, ML
De Vroey, V
Hertogs, K
Tanuri, A
机构
[1] Univ Fed Rio de Janeiro, Mol Virol Lab, Dept Genet, BR-21944970 Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Inst Biomed, Dept Ciencias Morfol, Unidade Genet, BR-21944970 Rio De Janeiro, Brazil
[3] Ctr Dis Control & Prevent, HIV & Retrovirol Branch, Div AIDS STD & TB Lab Res, Atlanta, GA 30333 USA
[4] VIRCO NV, Tibotec, B-2800 Mechelen, Belgium
关键词
D O I
10.1128/AAC.46.9.3075-3079.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The prevalence of mutations that confer resistance to protease inhibitors and to nucleoside and normucleoside reverse transcriptase inhibitors in 49 blood samples from drug-naive human immunodeficiency virus type 1-infected blood donors living in Rio de Janeiro state, Brazil, in 1998 was evaluated genotypically and phenotypically.
引用
收藏
页码:3075 / 3079
页数:5
相关论文
共 35 条
[31]   Antiretroviral therapy: state of the HAART [J].
Vella, S ;
Palmisano, L .
ANTIVIRAL RESEARCH, 2000, 45 (01) :1-7
[32]  
Vicente ACP, 2000, J ACQ IMMUN DEF SYND, V23, P327
[33]   Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naive HIV-1 infected US military personnel [J].
Wegner, SA ;
Brodine, SK ;
Mascola, JR ;
Tasker, SA ;
Shaffer, RA ;
Starkey, MJ ;
Barile, A ;
Martin, GJ ;
Aronson, N ;
Emmons, WW ;
Stephan, K ;
Bloor, S ;
Vingerhoets, J ;
Hertogs, K ;
Larder, B .
AIDS, 2000, 14 (08) :1009-1015
[34]   Prevalence of mutations associated with reduced antiretroviral drug susceptibility among human immunodeficiency virus type 1 seroconverters in the United States, 1993-1998 [J].
Weinstock, H ;
Respess, R ;
Heneine, W ;
Petropoulos, CJ ;
Hellmann, NS ;
Luo, CC ;
Pau, CP ;
Woods, T ;
Gwinn, M ;
Kaplan, J .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (01) :330-333
[35]   Transmission of antiretroviral-drug-resistant HIV-1 variants [J].
Yerly, S ;
Kaiser, L ;
Race, E ;
Bru, JP ;
Clavel, F ;
Perrin, L .
LANCET, 1999, 354 (9180) :729-733